Fussy eaters: the favoured food of Salmonella
As antibiotic resistance increases the search for new
anti-bacterial treatments becomes more and more important. One way to
design anti-bacterials is to find specific biochemical pathways that the
bacteria require to survive, and develop drugs that block off these
pathways. Some pathways are better targets than others and for Salmonella
bacteria it was thought that pathways dealing with nutrient metabolises
would be a lost cause. Salmonella lives in the intestine, which hosts a
whole variety of different nutrients, so surely preventing the bacteria
from using a specific one wouldn’t cause them much undue distress.
It’s been found, however, that as they grow and spread in
the inflamed intestine the bacteria are heavily reliant on one
particular nutrient: fructose-asparagine.
The importance of fructose-asparagine metabolism was originally
discovered during experiments designed to identify interactions between
the pathogenic Salmonella and the normal bacterial flora in the gut. Salmonella
mutants, without the genes required to metabolise fructose-asparagine,
were introduced into normal mice (with all their gut flora) and into
mice who had been treated with antibiotics to remove their gut bacteria.
When compared to the wild type salmonella it was found that there was
no difference in the normal mice whose gut bacteria were preventing the Salmonella from causing inflammation and disease. However in the antibiotic treated mice, the mutant Salmonella were struggling to cause any inflammation at all.
What these results suggest is that Salmonella might be happy
to survive on a range of nutrients while it’s just hanging around in
the intestine, but as soon as it becomes pathogenic and starts causing
inflammation it preferentially metabolises fructose-asparagine.
The image above shows a proposed model of how the fructose-asparagine is used by the Salmonella, based
on the properties of the identified genes. The fructose-asparagine
diffuses through the bacterium outer membrane and looses a small section
of the molecule (the -NH2 group) in the inter-membrane space. It is
then transported through the inner membrane and into the cell where the
rest of the metabolises occurs, breaking the fructose-asparagine into
glucose-6-P (a simple sugar that can be used for energy) and aspartate.
As well as being seemingly vital for bacterial survival during the
inflammatory disease, this also represents a novel pathway not found in
any other organism. This makes the fructose-asparagine pathway a perfect
target for anti-bacterial therapies as molecules that target this
pathway will not harm the human host. The high specificity of such a
molecule would also reduce damage to the normal bacterial flora within
the gut, and specifically target Salmonella causing an inflammatory illness.
—
Reference: Ali MM, Newsom DL, González JF, Sabag-Daigle A, Stahl C,
et al. (2014) Fructose-Asparagine Is a Primary Nutrient during Growth
of Salmonella in the Inflamed Intestine. PLoS Pathog 10(6): e1004209. doi:10.1371/journal.ppat.1004209
Comments
Post a Comment